G Otto
Overview
Explore the profile of G Otto including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
354
Citations
2398
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Darstein F, Hauser F, Mittler J, Zimmermann A, Lautem A, Hoppe-Lotichius M, et al.
Transplant Proc
. 2020 Mar;
52(3):926-931.
PMID: 32139278
Background: In past decades, liver transplant (LT) patients were not routinely screened for hepatitis E virus (HEV) infection, and thus it might have been misdiagnosed as an acute rejection episode....
2.
Darstein F, Hoppe-Lotichius M, Vollmar J, Weyer-Elberich V, Zimmermann A, Mittler J, et al.
Eur J Intern Med
. 2017 Dec;
51:41-45.
PMID: 29229303
Background: Cardiovascular disease is a serious problem of liver transplant (LT) recipients because of increased cardiovascular risk due to immunosuppressive therapy, higher age, intraoperative risk and comorbidities (such as diabetes...
3.
Grossman R, Abel B, Angiuoli S, Barrett J, Bassett D, Bramlett K, et al.
Clin Pharmacol Ther
. 2017 Feb;
101(5):589-592.
PMID: 28187516
The cancer community understands the value of blood profiling measurements in assessing and monitoring cancer. We describe an effort among academic, government, biotechnology, diagnostic, and pharmaceutical companies called the Blood...
4.
Duvinage Nee Krey C, Nagels S, Hampel G, Kratz J, Aguilar A, Minouchehr S, et al.
Appl Radiat Isot
. 2016 Jun;
115:312.
PMID: 27263359
No abstract available.
5.
Watzka F, Fottner C, Miederer M, Schad A, Weber M, Otto G, et al.
Langenbecks Arch Surg
. 2015 Apr;
400(3):359.
PMID: 25846243
No abstract available.
6.
Hornstein I, Schwarz C, Ebbing S, Hoppe-Lotichius M, Otto G, Lang H, et al.
Langenbecks Arch Surg
. 2015 Mar;
400(3):333-9.
PMID: 25726026
Background: Only limited data exist on the treatment and outcome of adrenal metastases that derive from different primary tumor entities. Due to the lack of evidence, it is difficult to...
7.
Surgical therapy of neuroendocrine neoplasm with hepatic metastasis: patient selection and prognosis
Watzka F, Fottner C, Miederer M, Schad A, Weber M, Otto G, et al.
Langenbecks Arch Surg
. 2015 Feb;
400(3):349-58.
PMID: 25682055
Background: Patients with neuroendocrine neoplasms (NEN) develop hepatic metastases in 50-95 %. The aims of this study were to evaluate the outcome/prognosis of patients following hepatic surgery and to identify...
8.
Darstein F, Konig C, Hoppe-Lotichius M, Grimm D, Knapstein J, Mittler J, et al.
Clin Transplant
. 2013 Dec;
28(2):236-42.
PMID: 24372847
Unlabelled: Left ventricular hypertrophy (LVH) has been described in the context of cirrhotic cardiomyopathy. The influence of LVH on survival of liver transplant (LT) recipients has not been clarified. Therefore,...
9.
Greten T, Malek N, Schmidt S, Arends J, Bartenstein P, Bechstein W, et al.
Z Gastroenterol
. 2013 Nov;
51(11):1269-326.
PMID: 24243572
The interdisciplinary guidelines at the S3 level on the diagnosis of and therapy for hepatocellular carcinoma (HCC) constitute an evidence- and consensus-based instrument that is aimed at improving the diagnosis...
10.
Weiler N, Thrun I, Eberlin M, Foltys D, Heise M, Hoppe-Lotichius M, et al.
Transplant Proc
. 2013 Aug;
45(6):2321-5.
PMID: 23953543
Background: Immunosuppressive therapy after orthotopic liver transplantation (OLT) requires a high degree of patient compliance to guarantee safety and avoid side effects. In 2007, prolonged-release tacrolimus was launched in Europe...